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Abstract
Objective:  To  compare  the  efﬁcacy  of  two  concentrations  of  heparin  to  clear  the  lumen  of
in vitro  clotted  neonatal  peripherally  inserted  central  catheters  (PICCs).
Methods:  This  is  an  in  vitro,  experimental  quantitative  study  of  76  neonatal  2.0-Fr  PICCs  coag-
ulated in  vitro.  The  catheters  were  divided  into  two  groups  of  38  PICCs  each.  In  both  groups  an
infusion of  low  molecular  weight  heparin  was  administered  with  a  dose  of  25IU/mL  for  Group  1
and 50IU/mL  for  Group  2.  The  negative  pressure  technique  was  applied  to  the  catheters  of  both
groups at  5,  15  and  30min  and  at  4h  to  test  their  permeability.  Kaplan--Meier  survival  analysis
was used  to  verify  the  outcome  of  the  groups  according  to  time  intervals.
Results:  The  comparison  between  both  groups  in  the  ﬁrst  5min  showed  that  more  catheters
from Group  2  were  cleared  compared  to  Group  1  (57.9  vs.  21.1%,  respectively).  Kaplan--Meier
survival analysis  showed  that  less  time  was  needed  to  clear  catheters  treated  with  50IU/mL  of
heparin (p<0.001).
Conclusions:  The  use  of  low  molecular  weight  heparin  at  a  concentration  of  50IU/mL  was  more
effective in  restoring  the  permeability  of  neonatal  PICCs  occluded  in  vitro  by  a  clot,  and  the
use of  this  concentration  is  within  the  safety  margin  indicated  by  scientiﬁc  literature.
© 2015  Sociedade  de  Pediatria  de  São  Paulo.  Published  by  Elsevier  Editora  Ltda.  All  rights
reserved.DOI of original article: http://dx.doi.org/10.1016/j.rpped.2015.01.009
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Recém-nascido
Heparina  para  desobstruc¸ão  de  cateter  venoso  central  de  inserc¸ão periférica  no
recém-nascido:  estudo  in  vitro
Resumo
Objetivo:  Comparar  a  eﬁcácia  de  duas  concentrac¸ões  de  heparina  para  a  desobstruc¸ão  por
coágulo do  cateter  venoso  central  de  inserc¸ão  periférica  (CCIP)  neonatal  in  vitro.
Métodos: Estudo  experimental  in  vitro  quantitativo  que  usou  76  CCIPs  neonatais  de  tamanho
2 French  coagulados  in  vitro.  Os  cateteres  foram  divididos  em  dois  grupos  com  38  CCIPs  cada.
Ambos os  grupos  receberam  infusão  de  heparina  de  baixo  peso  molecular,  com  dose  de  25UI/mL
no Grupo  I  e  de  50UI/mL  no  Grupo  II.  Os  cateteres  de  ambos  os  grupos  foram  submetidos
à técnica  de  pressão  negativa  com  cinco,  15  e  30  minutos  e  com  quatro  horas  e  testou-se
sua permeabilidade.  Usou-se  a  análise  de  sobrevivência  para  veriﬁcar  o  desfecho  dos  grupos
conforme  os  intervalos  de  tempo.
Resultados:  A  comparac¸ão  dos  dois  grupos  no  intervalo  de  tempo  de  cinco  minutos  mostrou  um
número maior  de  desobstruc¸ão  de  cateteres  no  Grupo  II  (57,9%)  em  relac¸ão  ao  grupo  1  (21,1%).
A análise  de  Kaplan  Meier  indicou  menor  tempo  para  desobstruc¸ão  dos  cateteres  quando  a
heparina em  maior  concentrac¸ão  (50UI/mL)  foi  usada  (p<0,001).
Conclusões:  O  uso  de  heparina  de  baixo  peso  molecular  na  concentrac¸ão  de  50UI/mL  foi  mais
eﬁcaz na  restaurac¸ão  da  permeabilidade  de  CCIPs  neonatais  ocluídos  in  vitro  por  coágulo  e
situou-se  tal  concentrac¸ão  dentro  da  margem  de  seguranc¸a indicada  na  literatura  cientíﬁca.
© 2015  Sociedade  de  Pediatria  de  São  Paulo.  Publicado  por  Elsevier  Editora  Ltda.  Todos  os
direitos reservados.
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output  through  the  proximal  end.  Additionally,  cathetersIntroduction
The  peripherally  inserted  central  catheter  (PICC)  has  been
shown  to  be  safe  for  intravenous  infusion  of  solutions  in
neonates.1,2 It  has  a  lower  incidence  of  complications  when
compared  to  other  central  venous  catheters,  supporting  the
thesis  that  it  is  a  safe  and  useful  device  to  be  used  in  situa-
tions  to  be  used  when  venous  access  is  limited  and  difﬁcult.3
Eventually,  complications  can  occur,  anticipating  the
unscheduled  removal  of  the  catheter.2 Among  the  main
complications  are  obstructions,  with  rates  that  can  vary
from  11%  to  50%,  and  catheter  rupture.2--8 Obstruction
may  be  caused  by  thrombus  formation,  a  poorly  positioned
catheter  tip  or  drug  precipitation.9,10
These  complications  can  be  prevented  and  minimized
through  speciﬁc  interventions.  There  are  many  practices
related  to  maintaining  the  PICC  permeability,  although  there
is  little  scientiﬁc  evidence  on  the  best  thrombolytic  agent,
as  well  as  its  safe  and  effective  concentration  that  can  sup-
port  a  single  practice.11--13
Although  heparin  is  almost  universally  used  in  clinical
practice,  its  beneﬁts  have  not  been  ﬁrmly  established,  as
well  as  the  effective  and  safe  dose  of  this  substance  for
arterial  and  venous  catheters  in  neonatology.12,13 The  lack
of  scientiﬁc  evidence  and  standardization  through  protocols
leads  to  the  use  of  several  heparin  concentrations,  which
can  often  be  abusive  as  well  as  be  as  underdoses,  which
can  result  in  unknown  side  effects  or  failure  in  catheter
clearance.14
In  this  context,  the  aim  of  this  study  was  to  compare  two
different  concentrations  of  sodium  low  molecular  weight
heparin  (SLMWH)  regarding  its  efﬁcacy  to  restore  the  per-
meability  of  neonatal  PICC  obstructed  by  a  clot  in  the
laboratory.
t
eethod
his  is  an  experimental,  in  vitro  study  of  quantitative
pproach,  developed  in  the  Analysis  Laboratory  of  a  uni-
ersity  hospital  in  Londrina,  state  of  Paraná,  from  July  to
ecember  2013.  The  study  sample  consisted  of  76  PICC  used
n  newborns  admitted  at  the  Neonatal  Intensive  Care  Unit.
n  this  unit,  the  indication  for  PICC  use  is  the  administra-
ion  of  antibiotics  for  longer  than  7  days,  start  of  vasoactive
rugs,  need  for  glucose  infusion  rate  (GIR)  >7,  and  par-
nteral  nutrition;  thus,  all  the  catheters  used  in  this  study
eceived  all  or  some  of  these  therapies.  The  catheters  were
btained  from  the  Neonatal  Intensive  Care  Unit  (NICU)  of  the
bove-mentioned  hospital,  after  being  removed  from  the
ewborns  because  of  the  end  of  the  treatment.  After  they
ere  removed,  the  catheters  were  immediately  washed  with
 10mL  syringe,  ﬁlled  with  distilled  water,  at  least  twice,
ntil  they  were  clean,  and  tested  for  integrity  and  perme-
bility,  after  which  they  were  stored  in  the  original  catheter
lastic  packaging.  These  catheters  were  stored  in  a cabinet
way  from  light  or  moisture  for  approximately  6  months,  the
ecessary  time  to  obtain  a  sufﬁcient  number  of  catheters  to
tart  the  study.
The criteria  for  catheter  inclusion  were  minimum  length
f  11cm,  2.0-Fr  caliber,  made  of  polyurethane,  single  brand,
nd  having  remained  in  the  newborn  for  a  minimum  of  1
eek  and  a  maximum  of  30  days.  The  exclusion  criterion  was
he  impossibility  of  maintaining  catheter  permeability  after
ts  removal.  For  that  purpose,  the  catheters  were  tested
hrough  the  infusion  of  distilled  water  at  their  distal  end
sing  a  10mL  syringe,  and  the  visualization  of  the  waterhat  were  not  adequately  stored  after  their  removal  were
xcluded.
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Sample  calculation  was  obtained  through  a  ﬁle  contain-
ng  the  record  of  all  catheters  used  in  newborns  in  the  NICU,
hich  had  the  patient’s  name,  catheter  brand,  batch,  cal-
ber,  reason  for  catheter  installation,  length  of  catheter
ntroduced  and  reason  for  removal.  The  data  spanned  the
ast  6  months  of  the  year  prior  to  collection,  i.e.,  July  to
ecember  2012.  A  total  of  68  PICCs  were  removed  during
his  period  because  of  the  end  of  treatment  and/or  obstruc-
ions.  Considering  a  sampling  error  of  5%,  conﬁdence  level
f  95%  and  clearing  difference  between  Groups  I  and  II  of
0%,  the  necessity  of  having  36  catheters  in  each  group  was
eriﬁed.
In  most  newborns,  the  length  of  the  introduced  PICC
anges  from  8  to  28cm,  depending  on  the  newborn’s  length
nd  the  puncture  location.  Consequently,  for  the  study,  the
ICCs  were  cut  with  a  scalpel  at  a  speciﬁc  marking  on  each
atheter  that  indicated  11cm.  Subsequently,  the  76  PICCs
ere  divided  into  two  groups  of  38  catheters  each,  randomly
istributed,  regardless  of  storage  time,  as  they  had  already
een  tested  for  permeability,  and  were  properly  identiﬁed
s  Groups  I  and  II,  followed  by  the  numeric  sequence  1--38.
he  randomization  was  carried  out  through  drawing  lots.
or  that  purpose,  the  researcher  placed  76  catheters  on  the
orkbench  and  asked  the  biochemist  to  choose  38  catheters,
hich  were  called  Group  I,  and  the  other  38  catheters  left
n  the  workbench  were  called  Group  II.  These  PICCs  were
oagulated  in  vitro  using  human  blood  obtained  by  venipunc-
ure  from  two  healthy  employees,  who  accepted  to  donate
he  blood  and  gave  written  consent,  both  having  blood  type
 Rh+,  hematocrit  39.2%  (donor  1)  and  42.2%  (donor  2)  and
latelets  410,000  (donor  1)  and  400,000  (donor  2),  respec-
ively  --  that  is,  within  the  normal  range.  Immediately  after
ollection,  made  with  a  23G  scalp  vein  needle  and  a  10mL
yringe,  blood  was  transferred  to  1mL  syringes,  and  a  volume
f  0.04mL  was  introduced  into  each  of  the  catheters,  which
ere  arranged  on  a  surgical  ﬁeld.  This  volume  was  neces-
ary  because  a  10cm  catheter  obstruction  was  used,  which
orresponds  to  approximately  0.04mL  of  the  internal  volume
apacity  (priming).  Catheter  obstruction  was  performed  by
wo  professionals  with  proven  capacity  and  dexterity,  who
ere  previously  trained  to  prevent  clotting  of  blood  out-
ide  the  catheter.  The  mean  time  between  blood  collection
nd  the  obstruction  of  each  catheter  was  2min.  After  ﬁlling
he  catheters  with  blood,  the  distal  end  was  connected  to
 three-way  tap,  which  was  properly  closed,  whereas  the
roximal  end  was  occluded  with  a  Kelly  clamp  to  prevent
he  escape  of  blood  or  air-drying.  The  technique  used  in
his  research  to  perform  in  vitro  coagulation  and  the  perme-
bility  testing  of  the  catheters  was  based  on  another  study,
hich  aimed  to  test  a  new  technique  to  restore  permeability
f  PICCs  occluded  by  clots  in  the  laboratory.15
Then,  each  catheter  was  transferred  to  and  immersed
n  a  container  with  100mL  of  saline  heated  to  37 ◦C  in  order
o  simulate  the  body  temperature  of  the  neonate.  Each  con-
ainer  had  14  catheters  from  the  same  group.  The  containers
ith  the  catheters  were  placed  in  a  water  bath  (Quimis
parelhos  Cientíﬁcos  Ltda.),  keeping  the  solution  between
6.5  and  37 ◦C,  with  strict  temperature  control  through  ther-
ometers  immersed  in  the  solution.  The  catheters  were
mmersed  for  6h  and  then  removed  and  cut  at  the  10cm
arking  to  eliminate  any  damage  caused  to  the  catheter  by
he  preliminary  clamping.  Subsequently,  their  permeability
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as  tested  through  a  1mL  infusion  of  saline  solution,  consid-
ring  as  completely  obstructed  those  catheters  into  which
t  was  not  possible  to  infuse  the  saline  solution  and  from
hich  the  blood  could  not  be  drawn  by  the  syringe.  Then,
he  catheters  were  again  placed  in  the  water  bath  device  for
he  start  of  the  infusion  of  both  heparin  concentrations.  The
aboratory  room  was  used  exclusively  for  the  procedure,  and
o  professionals  other  than  the  researchers  were  allowed  to
nter.  The  room  temperature  was  maintained  between  22
nd  24 ◦C,  and  the  period  of  time  during  which  the  catheters
emained  in  the  saline  solution  was  chosen  so  as  to  not  affect
he  results.
The  SLMWH  (5000IU/mL)  was  used  due  to  its  mecha-
ism  of  action,  it  being  the  most  often  used  heparin  type
n  neonatal  intensive  care  units,  and  having  the  lowest
ost.  SLMWH  exerts  anticoagulant  action  by  activation  of
ntithrombin  III,  which  has  its  activity  accelerated  up  to
000  times  in  order  to  inhibit  coagulation  factors  IIa  and
a  and,  to  a  lesser  extent,  IXa,  XIa  and  XIIa.  Heparin  bind-
ng  to  antithrombin  III  depends  on  the  presence  of  a  single
entasaccharide  sequence  contained  in  approximately  one-
hird  of  heparin  molecules.  The  remaining  two-thirds  have
inimal  anticoagulant  activity  at  usual  therapeutic  con-
entrations.  This  pentasaccharide  sequence  confers  high
fﬁnity  of  the  SLMWH  to  the  antithrombin  III.  Any  hep-
rin  or  SLMWH  molecule  containing  the  pentasaccharide  can
nhibit  Xa  action  simply  by  activating  AT  III.  To  inactivate
hrombin  (IIa),  the  SLMWH  must  bind  to  the  antithrombin
II  and  the  factor  IIa  simultaneously,  forming  a ternary  com-
lex  that  only  occurs  with  longer  chains,  with  at  least  18
accharides.  In  addition  to  decreasing  the  anti-IIa  effect,
LMWH  has  other  pharmacokinetic  advantages,  such  as
ecreased  binding  to  plasma  proteins  and  acute  phase  pro-
eins,  decreased  binding  to  macrophages  and  endothelial
ells,  decreased  binding  to  platelets  and  platelet  factor
 (PF4),  and  decreased  binding  to  osteoblasts.  These  dif-
erences  result  in  therapeutic  advantages,  such  as  more
redictable  anticoagulant  response,  longer  plasma  half-life,
ncreased  bioavailability,  reduced  heparin-induced  throm-
ocytopenia  and  reduced  osteopenia.16
Group  I  received  an  infusion  of  SLMWH  at  a  concentration
f  25IU/mL,  diluted  in  saline  solution,  in  a  10mL  syringe;
roup  II  received  the  same  SLMWH  at  a  concentration
f  50IU/mL,  also  diluted  in  10mL  saline  solution.  The
esearcher  was  blinded  to  the  choice  of  group  to  which
he  catheter  belonged.  Two  nurses  participated  at  the  time
f  the  experiment,  one  of  whom  was  responsible  for  the
learing  of  Group  I  catheters,  whereas  the  other  nurse
as  responsible  for  Group  II.  Both  nurses  were  trained  to
erform  the  experiment,  and  they  had  a  time  period  of
min  to  perform  the  technique  for  each  catheter,  which  was
ontrolled  by  the  biochemist  using  a  digital  timer.  The  bio-
hemist  was  responsible  for  delivering  the  two  syringes,  one
ith  SLMWH  with  25IU/mL  and  the  other  with  50IU/mL,  and
nly  he  had  knowledge  of  the  concentrations  used  in  each
atheter.  According  to  the  literature,  the  recommended
ntermittent  doses  of  heparin  are  50--100IU/kg/dose  every
 h,  without  causing  signiﬁcant  changes  in  coagulation,17hich  was  not  exceeded  in  this  study,  as  the  maximum
oncentration  of  heparin  was  50IU/mL  every  4h  in  the
roup  with  the  highest  concentration.  The  choice  of  using
 concentration  lower  than  that  found  in  the  scientiﬁc
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PICCs excluded according to the exclusion criteria:
Catheters with length <11cm (n=4);
1.9Fr caliber catheters (n=2);
Catheters of other brands (n=2 )
Non-coagulated catheters during follow-u p
(n=2)
Total excluded: 10
Analyzed PICCs
(n=76)
PICCs assessed regarding the inclusion criteria :
Catheters with a minimum length of 11cm;
2.0Fr caliber catheters; polyurethane
catheters and single brand
(n=86)
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aFigure  1  Negative  pressure  technique.
literature  was  made  to  maintain  a  safe  dose  and  to  allow
lower  doses  to  be  used  in  the  neonatal  population.
The  negative  pressure  technique  was  used  for  the  clear-
ance  attempts,18 as  shown  in  Fig.  1.  The  technique  involves
the  use  of  a  three-way  tap,  connected  to  the  catheter,  with
two  10mL  syringes  connected  to  the  tap,  one  containing
10mL  of  heparin  solution  according  to  the  group,  and  the
other  one  empty.  The  content  of  the  catheter  was  drawn
to  the  10mL  graduation  using  the  empty  syringe,  forming  a
vacuum  inside,  with  this  route  being  closed  soon  after.  The
tap  route  containing  the  solution  was  then  opened,  aiming
to  ﬁll  the  catheter  with  just  the  volume  aspirated  by  the
vacuum.  The  system  was  thus  blocked,  and  the  negative
pressure  technique  was  repeated  four  times,  with  5,  15  and
30min  and  4h.  The  same  heparin  solution  was  used  in  the
four  intervals.  Always  prior  to  solution  infusion,  an  attempt
to  aspirate  the  blood  clot  and  evaluate  catheter  patency
was  made  and,  when  cleared,  subsequent  tests  were  not
performed.
At  the  end  of  each  attempt  in  both  groups,  the  heparin
solution  was  totally  aspirated,  while  also  trying  to  aspirate
the  clot,  and  the  permeability  was  tested  again  by  using
1mL  of  saline  solution  infusion  in  a  10mL  syringe.  Catheter
permeability  was  considered  to  be  restored  when  clot  suc-
tion  capacity  was  possible,  as  well  as  the  infusion  of  1mL
of  saline  solution  from  the  distal  end  to  the  proximal  end
of  the  catheter.  To  ensure  that  catheter  permeability  had
been  restored,  the  saline  solution  was  disposed  off  in  a
container  with  an  accurate  0.1mL  graduation,  so  that  the
researchers  could  verify  whether  the  entire  infused  volume
had  been  returned  to  the  container.  To  ensure  that  the  infu-
sion  rate  among  nurses  was  as  accurate  as  possible,  they
used  a  digital  timer  manipulated  by  the  biochemist,  who
controlled  the  time  of  1min  for  the  saline  infusion  by  the
professionals.  The  examiners  responsible  for  the  permeabil-
ity  test  were  the  nurses  responsible  for  groups  I and  II,  who
determined  whether  the  catheter  had  recovered  its  perme-
ability,  whereas  the  biochemist  was  the  second  to  conﬁrm
and  record  the  result.
If  catheter  permeability  was  not  achieved,  the  doses  of
heparin  were  repeated  ﬁve  more  times  at  the  two  assessed
concentrations,  with  new  dilutions  every  4h,  due  to  the
d
t
cFigure  2  Flowchart  of  neonatal  PICC  eligibility.
ime  of  heparin  stability.  The  maximum  time  for  catheter
learance  would  be  24h  after  the  infusion  of  the  ﬁrst  hep-
rin  concentration.  These  intervals  were  used  following  the
nformal  account  of  nurses  of  the  above-mentioned  NICU,
ho  already  used  them  in  a  protocol  for  clearing  catheters
ith  heparin  concentration  of  50IU/mL.
The  results  were  recorded  in  a  previously  structured
orm  and  entered  in  a  spreadsheet  using  Microsoft  Ofﬁce
xcel  2007.  Later,  survival  analysis  was  performed  using
aplan--Meier  curve,  and  the  log-rank  (Mantel--Cox),  Bres-
ow  (Generalized  Wilcoxon)  and  Tarone--Ware  tests  were
pplied  to  verify  the  development  of  the  groups  according  to
he  time  intervals.  The  conﬁdence  interval  was  set  at  95%.
The  research  was  carried  out  after  approval  of
he  Institutional  Review  Board  of  Universidade  Estad-
al  de  Londrina,  process  n.  CEP/UEL:  066/2013,  CAAE:
3890613.8.0000.5231,  and  was  performed  in  accordance
ith  the  required  ethical  standards.
esults
uring  the  data  collection  period,  the  daily  removal  of
ICCs  at  the  NICU  was  followed,  aiming  to  identify  eligi-
le  catheters  to  be  included  in  this  study  sample,  as  shown
n  Fig.  2. Finally,  76  catheters  were  included  in  the  sam-
le.  Therefore,  the  study  groups  consisted  of  38  catheters
ach  from  the  same  brand,  2.0-Fr  caliber  and  11cm  long,
ith  a  mean  time  of  use  of  30  days.  Of  these,  35  (46%)  were
sed  exclusively  in  partial  parenteral  nutrition  (PPN),  and
1  (54%)  were  used  for  the  infusion  of  antibiotics,  glucose
nd  electrolyte  solutions.The  behavior  of  groups  according  to  the  time  intervals  is
epicted  in  Fig.  3, showing  a  signiﬁcant  difference  between
he  behaviors  of  different  concentrations,  with  less  time  of
atheter  clearance  in  Group  II,  with  a  higher  concentration
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Figure  3  Kaplan--Meier  chart  for  time  of  clearance  of  76  PICCs
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alled by  clots  in  the  laboratory,  according  to  two  heparin  con-
entrations.
f  heparin.  After  performing  the  test  for  survival  distribu-
ion  equality  for  the  different  group  levels  (Table  1),  we
btained  p<0.001,  conﬁrming  that  Group  II,  with  the  higher
oncentration,  allows  clearance  in  less  time.
These  data  are  reafﬁrmed  in  Table  2,  which  indicates
hat  when  comparing  the  results  of  the  two  groups  dur-
ng  the  5-min  time  interval,  a  greater  number  of  catheters
as  cleared  in  Group  II  (57.9%),  when  compared  to  Group
 (21.1%),  whereas  in  the  4-h  time  interval  the  inverse
ccurred,  which  allows  us  to  conclude  that  the  catheters
rom  Group  II,  which  received  the  concentration  of  low
olecular  weight  heparin  of  50IU/mL,  showed  faster  clear-
nce  than  those  from  Group  I,  which  were  treated  with
5IU/mL  of  low  molecular  weight  heparin.
Table  1  Test  of  survival  distribution  equality  for  the  dif-
ferent group  levels.
Chi-square  df  p-value
Log  Rank  (Mantel--Cox)  13.183  1  <0.001
Breslow (Generalized  Wilcoxon)  13.483  1  <0.001
Tarone--Ware  13.591  1  <0.001
Table  2  Clearance  of  PICCs  obstructed  by  clots  in  the  lab-
oratory according  to  two  heparin  concentrations,  during  the
4 days  of  the  study.  Londrina,  2013.
Time  interval  Group  I  (25IU/mL)  Group  II  (50IU/mL)
n  %  n  %
5min  08/38  21.1  22/38  57.9
15min  07/30  23.3  06/16  37.5
30min  05/23  21.7  05/10  50
4h 18/18  100  05/05  100
Total 38/38  100  38/38  100
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iscussion
ntraluminal  obstruction  of  a  central  catheter  may  be  more
ommon  in  patients  with  PICCs  because,  as  insertion  occurs
hrough  peripheral  vessels  that  have  a  smaller  caliber  at
he  introduction,  the  catheter  occupies  most  of  the  lumi-
al  diameter,  hindering  blood  ﬂow,  allowing  clot  formation
nd,  consequently,  obstruction.  Another  factor  responsible
or  thrombus  formation  is  the  inappropriate  catheter  posi-
ioning,  which  can  lead  its  tip  to  lean  against  the  wall  of
he  vessel,  allowing  obstruction  to  occur.  In  addition,  the
elected  limb  may  contribute  to  this  complication,  as  limb
ovement  can  cause  catheter  dislocation,  facilitating  the
ormation  of  clots  and  obstruction.19 Thus,  there  is  an  option
o  perform  maneuvers  for  clot  clearance,  as  they  can  occur
ven  with  adequate  catheter  handling  and  maintenance,
nlike  the  obstruction  due  to  crystal  formation  caused  by
ncompatible  drugs  with  low  solubility,  which  is  considered
n  iatrogenic  event  by  nursing  care.
To  simulate  what  occurs  in  vivo, it  was  decided,  dur-
ng  the  catheter  coagulation  process,  to  immerse  them  in  a
olution  heated  at  36--37 ◦C,  in  order  to  mimic  the  body  tem-
erature  of  the  newborn,  stipulating  a  6-h  period  of  time  to
ubsequently  test  their  permeability.  This  time  interval  was
etermined  taking  into  account  one  of  the  most  widespread
ecommendations  to  maintain  PICC  permeability:  ﬂushing
he  catheter  at  pre-established  intervals,  usually  every  8h.20
onsidering  the  nursing  care  process,  the  catheter  is  usually
ushed  at  every  shift.  For  this  reason,  during  the  practice
f  nursing  care,  it  is  an  important  step  to  clean  the  catheter
efore  and  after  drug  administration,  when  the  interval  for
he  administration  of  these  drugs  exceeds  6--8h;  that  is,
he  team  should  be  able  to  identify  and  start  the  clear-
ng  maneuver  of  an  obstructed  catheter  as  early  as  possible
fter  the  start  of  the  event.
When  considering  that  the  obstruction  concept  also
ncludes  the  slowed  ﬂow  along  the  catheter,9 one  questions
hether  the  clearance  procedure  by  means  of  negative  pres-
ure  technique  with  heparin  concentration  should  also  be
sed  in  these  cases.  It  is  known  that  the  catheter  may  rup-
ure  if  syringes  with  volumes  <10mL  are  used,  since  the
ower  the  volume  of  the  syringe,  the  greater  the  pressure
xerted  on  the  catheter.  Therefore,  in  this  study,  we  only
sed  10mL  syringes  with  the  negative  pressure  technique,
nd  at  the  time  of  the  procedure,  all  the  plungers  were
ulled  up  to  the  mark  of  10mL.  Thus,  the  pressure  was  con-
rolled  and  it  was  assured  that  all  catheters  received  the
ame  pressure  during  the  clearance  process.
The  action  mechanism  of  the  heparin  depends  on  its
inding  to  a  plasma  cofactor,  the  antithrombin,  thereby
nactivating  thrombin  (factor  IIa)  and  the  activated  coagula-
ion  factor  X,  preventing  the  conversion  of  prothrombin  into
hrombin,  and  of  ﬁbrinogen  into  ﬁbrin.21 The  advantages  of
LMWH  include:  no  interference  of  diet  or  medications  on
ts  action  mechanism  and  minimum  monitoring;  when  com-
ared  to  unfractionated  heparin,  it  does  not  show  increased
isk  of  bleeding,  and  it  reduces  the  incidence  of  heparin-
nduced  thrombocytopenia  when  used  alone.22The  concentrations  of  heparin  (25  and  50IU/mL)  cho-
en  for  comparison  were  based  on  clinical  and  scientiﬁc
ractice  regarding  their  clearance  efﬁcacy  and  at  the  max-
mum  safe  dose,  to  prevent  adverse  effects  and  other
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complications  that  may  occur  during  their  use  in  neonates.17
Among  the  studies  using  different  concentrations  of  contin-
uous  or  intermittent  heparin  in  neonates,  no  adverse  events
were  found.12,13,23 This  study  decided  to  consider  the  lowest
concentration  of  heparin  considered  safe,  as  it  was  carried
out  in  vitro  and  it  was  not  possible  to  verify  the  occurrence
of  adverse  events  in  newborns.
This  study,  however,  tested  two  different  concentrations
of  heparin  associated  with  the  negative  pressure  technique.
Two  catheter  clearance  techniques  were  found  in  the  liter-
ature:  the  negative  pressure  technique,18 described  earlier,
and  the  standard  operating  procedure  (SOP)  technique.15
In  the  SOP  technique,  the  syringe  plunger  is  pulled  back
and  released  at  regular  intervals  in  the  catheter,  sending
a  shock  wave  that  displaces  the  clot  from  the  catheter
lumen,  allowing  the  thrombus  to  be  aspirated.15 Because
the  latter  technique  has  been  tested  in  3.0  and  4.0-Fr
catheters,  not  used  in  neonatology,  it  was  decided  to  use
the  negative  pressure  technique.  It  is  noteworthy  that
only  10mL  syringes  were  used  in  all  procedures  performed
with  catheters,  according  to  published  recommendations,
as  lower-volume  syringes  have  greater  intravascular  pres-
sure,  increasing  the  occurrence  of  adverse  events,  such  as
the  catheter  rupture.4,24 Catheter  clearance  attempts  made
by  means  of  positive  pressure,  even  with  the  infusion  of
thrombolytic  agents,  can  cause  catheter  rupture  due  to  high
resistance.  Therefore,  the  negative  pressure  technique  was
used,  which  provides  contact  of  the  thrombolytic  agent  with
the  clot  without  causing  positive  pressure,  which  facilitates
clot  removal.13
It  should  be  emphasized  that,  in  Group  II,  heparin  at  a
higher  concentration  was  more  effective  in  catheter  clear-
ance,  as  the  latter  occurred  within  a  shorter  period  of  time
when  compared  to  Group  I.  Perhaps,  the  interventions  per-
formed  resulted  from  the  association  of  heparin  with  the
negative  pressure  technique;  however,  one  cannot  make
this  claim,  as  the  study  was  not  designed  to  test  the  neg-
ative  pressure  technique  for  catheter  clearance.  During  the
experiment,  however,  the  criteria  related  to  the  negative
pressure  technique  were  maintained,  such  as  using  only
10mL  syringes,  which  was  considered  safer,  attempting  to
remove  the  clot  using  the  empty  syringe  before  the  solution
infusion,  maintaining  the  obstructed  catheter  immersed  in
solution  for  at  least  5min  before  attempting  suction,  which
is  the  minimum  time  for  heparin  to  act,  and  detaching  the
clot  from  the  lumen  catheter.  It  is  worth  mentioning  that  the
clot  is  not  diluted  by  the  heparin  action,  but  the  latter  allows
the  clot  to  detach  itself  from  the  catheter  wall  --  hence  the
importance  of  aspirating  it  to  prevent  further  obstruction  or
the  introduction  of  the  clot  into  the  newborn’s  bloodstream.
The  fact  that  the  clots  from  all  catheters  were  aspi-
rated  into  the  syringe  before  the  permeability  test  does  not
allow  us  to  afﬁrm  the  efﬁcacy  and  safety  of  the  experiment.
The  negative  pressure  technique  associated  with  the  tested
heparin  concentrations  led  to  the  restoration  of  catheter
permeability  and  thrombus  aspiration  visualization,  pre-
venting  it  from  being  introduced  into  the  bloodstream,
which  can  lead  to  severe  consequences  for  the  neonate.
Although  no  clot  was  visualized  after  the  saline  infusion  dur-
ing  the  permeability  test,  it  is  not  possible  to  afﬁrm  the  total
absence  of  blood  clots,  as  the  solution  was  not  ﬁltered  and
analyzed  microscopically.theter  265
One  must  remember  that  the  measures  used  to  maintain
ICC  permeability  are  essential  for  appropriate  intravenous
herapy.  However,  when  catheter  obstruction  eventually
ccurs,  many  damages  to  the  newborns  are  identiﬁed,  such
s  the  need  for  repeated  punctures,  which  are  painful  and
an  be  difﬁcult,  discontinuation  of  drug  therapy  or  contin-
ous  parenteral  nutrition,  more  catheter  handling,  which
redisposes  to  infection,  and  increased  stress  levels  for  the
ewborn  and  the  staff.
It  should  be  emphasized  that,  although  the  study  sought
o  simulate  the  clinical  condition  of  the  catheter  into  the
ewborn’s  vessel,  it  was  carried  out  in  a  laboratory,  which
rings  some  limitations  due  to  the  absence  of  factors  present
n  the  bloodstream,  such  as  the  turbulence  of  blood  within
he  vessels.  Another  study  limitation  was  the  impossibility
f  verifying  microclot  detachment  from  the  catheter  after
he  saline  infusion  to  verify  the  catheter’s  permeability,  and
hus,  other  studies  are  necessary  to  allow  this  solution  to
e  ﬁltered  and  analyzed  microscopically,  as  the  presence
f  microclots  could  trigger  new  obstructions  or  emboliza-
ion  into  the  bloodstream.  Another  limitation  of  the  study  is
elated  to  previous  use  of  the  catheters,  as  several  of  them
ight  be  more  likely  to  have  clots  more  or  less  adhered  to
hem,  as  they  were  used  in  different  neonates  for  infusion
f  PPN,  antibiotics,  and  glucose  and  electrolyte  solutions,
hich  would  not  depend  on  the  type  of  heparin  used.
For  the  nursing  staff  to  obtain  successful  catheter  implan-
ation,  they  should  be  aware  of  the  risks  involved  in  its  use.
ursing  care  is  essential  to  maintain  the  PICC,  and  the  identi-
cation  of  possible  complications  related  to  its  use  becomes
 necessity  for  professionals  who  work  directly  with  catheter
andling.10 Thus,  scientiﬁc  evidence  research  is  essential  for
he  decision-making  process  of  optimizing  the  PICC,  par-
icularly  regarding  what  is  the  most  effective  solution  in
reventing  catheter  obstruction.25
It  can  be  concluded  that  the  use  of  low  molecular  weight
eparin  at  a  concentration  of  50IU/mL  was  more  effective
n  restoring  permeability  of  neonatal  PICCs  (2.0Fr)  occluded
n  vitro  by  a  clot  than  the  25IU/mL  concentration,  empha-
izing  that  these  concentrations  are  still  within  the  safety
argin  indicated  in  the  literature.
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